Long-term outcome and metastatic risk after endoscopic resection of superficial esophageal squamous cell carcinoma

American Journal of Gastroenterology

Volumn 108, Issue 4, 2013, Pages 544-551

  Yamashina, Takeshi ^a   Ishihara, Ryu ^a   Nagai, Kengo ^a   Matsuura, Noriko ^a   Matsui, Fumi ^a   Ito, Takashi ^a   Fujii, Mototsugu ^a   Yamamoto, Sachiko ^a   Hanaoka, Noboru ^a   Takeuchi, Yoji ^a   Higashino, Koji ^a   Uedo, Noriya ^a   Iishi, Hiroyasu ^a  

^a OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER INVASION; CANCER MORTALITY; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CANCER RISK; CANCER SURVIVAL; CAUSE OF DEATH; CAUSE SPECIFIC SURVIVAL; DISTANT METASTASIS; ENDOSCOPIC MUCOSAL RESECTION; ENDOSCOPIC SUBMUCOSAL DISSECTION; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS HEMORRHAGE; ESOPHAGUS PERFORATION; ESOPHAGUS RESECTION; ESOPHAGUS STENOSIS; FEMALE; FOLLOW UP; HUMAN; LAMINA PROPRIA; LONG TERM CARE; LYMPH NODE METASTASIS; LYMPH VESSEL METASTASIS; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PNEUMOMEDIASTINUM; PRIORITY JOURNAL; STOMACH MUSCLE; SURVIVAL RATE;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CHEMOTHERAPY, ADJUVANT; ESOPHAGEAL NEOPLASMS; ESOPHAGOSCOPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; POSTOPERATIVE COMPLICATIONS; RADIOTHERAPY, ADJUVANT; REMISSION INDUCTION; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84875926223     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2013.8     Document Type: Article

References (28)

1. Parkin DM, Bray F, Ferlay J et al. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74-108.
2. Enzinger PC, Mayer RJ. Esophageal cancer. N Engl J Med. 2003; 349: 2241-52.
3. Kodama M, Kakegawa T. Treatment of superficial cancer of the esophagus: a summary of responses to a questionnaire on superficial cancer of the esophagus in Japan. Surgery 1998; 123: 432-9.
4. Ishihara R, Tanaka H, Iishi H et al. Long-term outcome of esophageal mucosal squamous cell carcinoma without lymphovascular involvement afterendoscopic resection. Cancer 2008; 112: 2166-72.
5. Fujishiro M, Yahagi N, Kakushima N et al. Endoscopic submucosal dissection of esophageal squamous cell neoplasms. Clin Gastroenterol Hepatol 2006; 4: 688-94.
6. Takahashi H, Arimura Y, Masaoo H et al. Endoscopic submucosal dissection is superior to conventional endoscopic resection as a curative treatment for early squamous cell carcinoma of the esophagus (with video). Gastrointest Endosc 2010; 72: 255-64.
7. Katada C, Muto M, Momma K et al. Clinical outcome after endoscopic mucosal resection for esophageal squamous cell carcinoma invading the muscularis mucosae-a multicenter retrospective cohort study. Endoscopy 2007; 39: 779-83.
8. Shimizu Y, Tsukagoshi H, Fujita M et al. Long-term outcome after endoscopic mucosal resection in patients wiThesophageal squamous cell carcinoma invading the muscularis mucosae or deeper. Gastrointest Endosc 2002; 56: 387-90.
9. Igaki H, Kato H, Tachimori Y et al. Clinicopathologic characteristics and survival of patients with clinical stage I squamous cell carcinomas of thethoracic esophagus treated with three-field lymph node dissection. Eur J Cardiothorac Surg 2001; 20: 1089-94.
10. Kato H, Sato A, Fukuda H et al. A phase II trial of chemoradiotherapy for stage I esophageal squamous cell carcinoma: Japan Clinical Oncology Group Study (JCOG9708). Jpn J Clin Oncol 2009; 39: 638-43.
11. Yamamoto S, Ishihara R, Motoori M et al. Comparison between definitive chemoradiotherapy and esophagectomy in patients with clinical stage I esophageal squamous cell carcinoma. Am J Gastroenterol 2011; 106: 1048-54.
12. Araki K, Ohno S, Egashiraashira A et al. Pathologic features of superficial esophageal squamous cell carcinoma with lymph node and distal metastasis. Cancer 2002; 94: 570-5.
13. Eguchi T, Nakanishi Y, Shimoda T et al. Histopathological criteria for additional treatment after endoscopic mucosal resection for esophageal cancer: analysis of 464 surgically resected cases. Mod Pathol 2006; 19: 475-80.
14. Tajima Y, Yoshimura K, Kusano M et al. Histopathologic findings predicting lymph node metastasis and prognosis of patients with superficial esophageal carcinoma: analysis of 240 surgically resected tumors. Cancer 2000; 88: 1285-93.
15. Kim DU, Lee JH, Min BH et al. Risk factors of lymph node metastasis in T1 esophageal squamous cell carcinoma. J Gastroenterol Hepatol 2008; 23: 619-25.
16. Japan Esophageal Society. Japanese Classification of Esophageal Cancer, tenThedition: part I. Esophagus 2009; 6: 1-58.
17. Muto M, Hironaka S, Nakane M et al. Association of multiple Lugolvoiding lesions with synchronous and metachronous esophageal squamous cell carcinoma in patients with head and neck cancer. Gastrointest Endosc 2002; 56: 517-21.
18. Kumagai Y, Toi M, Inoue H et al. Dynamism of tumour vasculature in the early phase of cancer progression: outcomes from oesophageal cancer research. Lancet Oncol 2002; 3: 604-10.
19. Yoshida T, Inoue H, Usui S et al. Narrow-band imaging system with magnifying endoscopy for superficial esophageal lesions. Gastrointest Endosc 2004; 59: 288-95.
20. Tada M, Murakami A, Karita M et al. Endoscopic resection of early gastric cancer. Endoscopy 1993; 25: 445-50.
21. Inoue H, Takeshita K, Hori H et al. Endoscopic mucosal resection with a cap-fitted panendoscope for esophagus, stomach, and colon mucosal lesions. Gastrointest Endosc 1993; 39: 58-62.
22. Oyama T, Tomori A, Hotta K et al. Endoscopic submucosal dissection of early esophageal cancer. Clin Gastroenterol Hepatol 2005; 3: 67-70.
23. Prasad GA, Wu TT, Wigle DA et al. Endoscopic and surgical treatment of mucosal (T1a) esophageal adenocarcinoma in Barrett's esophagus. Gastroenterology 2009; 137: 815-23.
24. Pech O, Behrens A, May A et al. Long-term results and risk factor analysis for recurrence after curative endoscopic therapy in 349 patients with high-grade intraepithelial neoplasia and mucosal adenocarcinoma in Barrett's oesophagus. Gut 2008; 57: 1200-6.
25. Pech O, May A, Gossner L et al. Curative endoscopic therapy in patients wiThearly esophageal squamous-cell carcinoma or high-grade intraepithelial neoplasia. Endoscopy 2007; 39: 30-5.
26. Shimizu Y, Tukagoshi H, Fujita M et al. Metachronous squamous cell carcinoma of the esophagus arising after endoscopic mucosal resection. Gastrointest Endosc 2001; 54: 190-4.
27. Hori K, Okada H, Kawahara Y et al. Lugol-voiding lesions are an important risk factor for a second primary squamous cell carcinoma in patients wiThesosphageal cancer or head and neck cancer. Am J Gastroenterol 2011; 106: 858-66.
28. Sato Y, Motoyama S, Maruyama K et al. A second malignancy is the major cause of death among thoracic squamous cell esophageal cancer patients negative for lymph node involvement. J Am Coll Surg 2005; 201: 188-93.